Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
Sjöberg M, Walch A, Meshkat M, Gustavsson A, Järnerot G, Vogelsang H, Hertervig E, Novacek G, Friis-Liby I, Blomquist L, Angelberger S, Karlen P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Dejaco C, Magnuson A, Halfvarson J, Reinisch W, Tysk C. Sjöberg M, et al. Among authors: dejaco c. Inflamm Bowel Dis. 2012 Feb;18(2):212-8. doi: 10.1002/ibd.21680. Epub 2011 Mar 15. Inflamm Bowel Dis. 2012. PMID: 21438096
Expression of CD44v6 in ulcerative colitis and Crohn's disease.
Reinisch W, Heider KH, Oberhuber G, Dejaco C, Adolf GR. Reinisch W, et al. Among authors: dejaco c. Lancet. 1996 Apr 13;347(9007):1049. doi: 10.1016/s0140-6736(96)90190-7. Lancet. 1996. PMID: 8606594 No abstract available.
Healthy offspring in parents both receiving thiopurines.
Oefferlbauer-Ernst A, Reinisch W, Miehsler W, Vogelsang H, Dejaco C. Oefferlbauer-Ernst A, et al. Among authors: dejaco c. Gastroenterology. 2004 Feb;126(2):628. doi: 10.1053/j.gastro.2003.12.030. Gastroenterology. 2004. PMID: 14765398 No abstract available.
Infliximab: lack of efficacy on perforating complications in Crohn's disease.
Miehsler W, Reinisch W, Kazemi-Shirazi L, Dejaco C, Novacek G, Ferenci P, Herbst F, Karner J, Téleky B, Schober E, Vogelsang H. Miehsler W, et al. Among authors: dejaco c. Inflamm Bowel Dis. 2004 Jan;10(1):36-40. doi: 10.1097/00054725-200401000-00006. Inflamm Bowel Dis. 2004. PMID: 15058525
294 results